Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark. [electronic resource] by
- Hansen, O P
- Pedersen-Bjergaard, J
- Ellegaard, J
- Brincker, H
- Boesen, A M
- Christensen, B E
- Drivsholm, A
- Hippe, E
- Jans, H
- Jensen, K B
Producer: 19910726
In:
Leukemia vol. 5
Availability: No items available.
|
|
31.
|
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML. [electronic resource] by
- de Nully Brown, P
- Hoffmann, T
- Hansen, O P
- Boesen, A M
- Grønbaek, K
- Hippe, E
- Jensen, M K
- Thorling, K
- Storm, H H
- Pedersen-Bjergaard, J
Producer: 19970211
In:
Leukemia vol. 11
Availability: No items available.
|
|
32.
|
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support. [electronic resource] by
- Johnsen, H E
- Björkstrand, B
- Carlson, K
- Gruber, A
- Blystad, A
- Fast, A
- Boesen, A M
- Björkholm, M
- Sallerfors, B
- Ruutu, T
- Carneskog, J
- Malm, A
- Geisler, C
- Lehtinen, M
- Schrøder, H
- Brinch, L
- Remes, K
- Tidefelt, U
- Heilmann, C
- Hörnsten, P
- Thorling, K
- Daugaard, G
Producer: 19970819
In:
Leukemia & lymphoma vol. 24
Availability: No items available.
|